Combining blinatumomab and donor lymphocyte infusion in B-ALL patients relapsing after allogeneic hematopoietic cell transplantation: a study of the SFGM-TC
Paul Chauvet, Annalisa Paviglianiti, Myriam Labopin, Hélène Labussière, Nicolas Boissel, Marie Robin, Natacha Maillard, O Marie, Édouard Forcade, Xavier Poiré, Sylvain Chantepie, Anne Huynh, Claude Eric Bulabois, Mathieu Leclerc, Sébastien Maury, Patrice Chevallier, Thomas Cluzeau, Jean-Baptiste Méar, Jérôme Cornillon, Karin Bilger, Célestine Simand, Yves Béguin, Marie‐Thérèse Rubio, Ibrahim Yakoub‐Agha, Éolia Brissot
Topics & Concepts
BlinatumomabMedicineDonor lymphocyte infusionHematopoietic stem cell transplantationTransplantationInternal medicineAdverse effectHematopoietic cellOncologyLeukemiaLymphoblastic LeukemiaStem cellHaematopoiesisGeneticsBiologyAcute Lymphoblastic Leukemia researchChronic Myeloid Leukemia TreatmentsCAR-T cell therapy research